{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:35:33Z","timestamp":1793054133632,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T00:00:00Z","timestamp":1200355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00417-007-0757-4","type":"journal-article","created":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T10:52:29Z","timestamp":1200307949000},"page":"739-746","source":"Crossref","is-referenced-by-count":9,"title":["Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma"],"prefix":"10.1007","volume":"246","author":[{"given":"Minna","family":"Helin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"R\u00f6nkk\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Puustj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Ter\u00e4svirta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Uusitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,15]]},"reference":[{"key":"757_CR1","first-page":"307","volume-title":"The enzymes, vol. XVI","author":"EA Dennis","year":"1983","unstructured":"Dennis EA (1983) Phospholipases. In: Boyer P (eds) The enzymes, vol. XVI. Academic Press, New York, pp 307\u2013351"},{"key":"757_CR2","first-page":"3057","volume":"269","author":"EA Dennis","year":"1994","unstructured":"Dennis EA (1994) Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269:3057\u201313060","journal-title":"J Biol Chem"},{"key":"757_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3565(24)39138-4","volume":"294","author":"BS Cummings","year":"2000","unstructured":"Cummings BS, McHowat J, Schnellmann RG (2000) Phospholipase A2s in cell injury and death. J Pharmacol Exp Ther 294:793\u2013799","journal-title":"J Pharmacol Exp Ther"},{"key":"757_CR4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1248\/bpb.27.1179","volume":"27","author":"M Murakami","year":"2004","unstructured":"Murakami M (2004) Hot topics in phospholipase A2 field. Biol Pharm Bull 27:1179\u20131182","journal-title":"Biol Pharm Bull"},{"key":"757_CR5","first-page":"72","volume":"1585","author":"MM Taketo","year":"2002","unstructured":"Taketo MM, Sonoshita M (2002) Phospholipase A2 and apoptosis. Biochem Biophys Acta 1585:72\u201376","journal-title":"Biochem Biophys Acta"},{"key":"757_CR6","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1074\/jbc.M109777200","volume":"277","author":"SA Beers","year":"2002","unstructured":"Beers SA, Buckland AG, Koduri RS, Cho W, Gelb MH, Wilton DC (2002) The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem 277:1788\u20131793","journal-title":"J Biol Chem"},{"key":"757_CR7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0006-291X(92)90849-G","volume":"186","author":"J Kishino","year":"1992","unstructured":"Kishino J, Tohkin M, Arita H (1992) Proliferative effect of phospholipase A2 in rat chondrocyte via its specific binding sites. Biochem Biophys Res Commun 186:1025\u20131031","journal-title":"Biochem Biophys Res Commun"},{"key":"757_CR8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0005-2760(93)90246-6","volume":"1164","author":"H Tokumoto","year":"1993","unstructured":"Tokumoto H, Croxtall JD, Choudhury Q, Flower RJ (1993) Phospholipase A2-induced stimulation of A549 lung adenocarcinoma cell line proliferation. Biochim Biophys Acta 1164:236\u2013242","journal-title":"Biochim Biophys Acta"},{"key":"757_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/3-540-10961-7_3","volume":"91","author":"HM Verheij","year":"1981","unstructured":"Verheij HM, Slotboom AJ, de Haas GH (1981) Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol 91:91\u2013203","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"757_CR10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-7","volume":"161","author":"EA Dennis","year":"2000","unstructured":"Dennis EA (2000) Phospholipase A2 in eicosanoid generation. Am J Respir Crit Care Med 161:S32\u2013S35","journal-title":"Am J Respir Crit Care Med"},{"key":"757_CR11","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1074\/jbc.273.23.14411","volume":"273","author":"M Murakami","year":"1998","unstructured":"Murakami M, Shimbara S, Kambe T, Kuwata H, Winstead MV, Tischfield JA, Kudo I (1998) The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release. Type IIA and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2. J Biol Chem 273:14411\u201314423","journal-title":"J Biol Chem"},{"key":"757_CR12","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1074\/jbc.274.5.3103","volume":"274","author":"M Murakami","year":"1999","unstructured":"Murakami M, Kambe T, Shimbara S, Kudo I (1999) Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem 274:3103\u20133115","journal-title":"J Biol Chem"},{"key":"757_CR13","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood.V96.12.3809","volume":"96","author":"MT Rizzo","year":"2000","unstructured":"Rizzo MT, Nguyen E, Aldo-Benson M, Lambeau G (2000) Secreted phospholipase A2 induces vascular endothelial cell migration. Blood 96:3809\u20133815","journal-title":"Blood"},{"key":"757_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1194\/jlr.R300016-JLR200","volume":"45","author":"GY Sun","year":"2003","unstructured":"Sun GY, Xu J, Jensen MD, Simonyi A (2003) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45:205\u2013213","journal-title":"J Lipid Res"},{"key":"757_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000128064","volume":"11","author":"T Schroder","year":"1979","unstructured":"Schroder T, Somerharju P, Lempinen M (1979) Phospholipase A2 in serum and ascitic exudate in experimental acute haemorrhagic pancreatitis in pigs. Eur Surg Res 11:172\u2013178","journal-title":"Eur Surg Res"},{"key":"757_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gut.40.3.386","volume":"40","author":"W Uhl","year":"1997","unstructured":"Uhl W, Schrag HJ, Schmitter N, Nevalainen TJ, Aufenanger J, Wheatley AM, Buchler MW (1997) Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats. Gut 40:386\u2013392","journal-title":"Gut"},{"key":"757_CR17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/hh1601.095598","volume":"89","author":"E Hurt-Camejo","year":"2001","unstructured":"Hurt-Camejo E, Camejo G, Peilot H, \u00d6orni K, Kovanen P (2001) Phospholipase A2 in vascular disease. Circ Res 89:298\u2013304","journal-title":"Circ Res"},{"key":"757_CR18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/03009749409103030","volume":"23","author":"P Kortekangas","year":"1994","unstructured":"Kortekangas P, Aro HT, Nevalainen TJ (1994) Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand J Rheumatol 23:68\u201372","journal-title":"Scand J Rheumatol"},{"key":"757_CR19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajhp\/62.7.691","volume":"62","author":"DA Lee","year":"2005","unstructured":"Lee DA, Higginbotham EJ (2005) Glaucoma and its treatment: a review. Am J Health Syst Pharm 62:691\u2013699","journal-title":"Am J Health Syst Pharm"},{"key":"757_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200522010-00001","volume":"22","author":"RE Marquis","year":"2005","unstructured":"Marquis RE, Whitson JT (2005) Management of glaucoma: focus on pharmacological therapy. Drugs Aging 22:1\u201321","journal-title":"Drugs Aging"},{"key":"757_CR21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363:1711\u20131720","journal-title":"Lancet"},{"key":"757_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9394(14)76730-3","volume":"112","author":"JD Brandt","year":"1991","unstructured":"Brandt JD, Wittpenn JR, Katz LJ, Steinmann WN, Spaeth GL (1991) Conjunctival impression cytology in patients with glaucoma using long-term topical medication. Am J Ophthalmol 112:97\u2013301","journal-title":"Am J Ophthalmol"},{"key":"757_CR23","first-page":"35","volume":"48","author":"A Nenciu","year":"2004","unstructured":"Nenciu A, Stefan C, Ardelean C (2004) Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication. Oftalmologia 48:35\u201342","journal-title":"Oftalmologia"},{"key":"757_CR24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.all.0000183112.86181.9e","volume":"5","author":"C Baudouin","year":"2005","unstructured":"Baudouin C (2005) Allergic reaction to topical eyedrops. Curr Opin Allergy Clin Immunol 5:459\u2013463","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"757_CR25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00417-006-0440-1","volume":"245","author":"S R\u00f6nkk\u00f6","year":"2007","unstructured":"R\u00f6nkk\u00f6 S, Rekonen P, Kaarniranta K, Puustj\u00e4rvi T, Ter\u00e4svirta M, Uusitalo H (2007) Matrix metalloproteinases and their inhibitors in chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 245:697\u2013704","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"757_CR26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/bj20020142","volume":"364","author":"J Balsinde","year":"2002","unstructured":"Balsinde J (2002) Roles of various phospholipases A2 in providing lysophospholipid acceptors for fatty acid phospholipid incorporation and remodelling. Biochem J 364:695\u2013702","journal-title":"Biochem J"},{"key":"757_CR27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.57.9.550","volume":"57","author":"OS Jamal","year":"1998","unstructured":"Jamal OS, Conaghan PG, Cunningham AM, Brooks PM, Munro VF, Scott KF (1998) Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium. Ann Rheum Dis 57:550\u2013558","journal-title":"Ann Rheum Dis"},{"key":"757_CR28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00384-002-0402-y","volume":"17","author":"O Yamaguchi","year":"2002","unstructured":"Yamaguchi O, Sugimura K, Ishizuka K, Suzuki K, Hasegawa K, Ohtsuka K, Honma T, Asakura H (2002) Correlation between serum phospholipase A2 IIA levels and histological activity in patients with ulcerative colitis. Int J Colorectal Dis 17:311\u2013316","journal-title":"Int J Colorectal Dis"},{"key":"757_CR29","first-page":"G706","volume":"273","author":"LW Dong","year":"1997","unstructured":"Dong LW, Yang J, Tong LJ, Hsu HK, Liu MS (1997) Group II phospholipase A2 gene expression in transcriptionally regulated in rat liver during sepsis. Am J Physiol 273:G706\u2013G712","journal-title":"Am J Physiol"},{"key":"757_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/scdb.1997.0151","volume":"8","author":"MA Gij\u00f3n","year":"1997","unstructured":"Gij\u00f3n MA, Leslie CC (1997) Phospholipases A2. Semin Cell Dev Biol 8:297\u2013303","journal-title":"Semin Cell Dev Biol"},{"key":"757_CR31","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/S0021-9258(18)83616-X","volume":"264","author":"RM Kramer","year":"1989","unstructured":"Kramer RM, Hession C, Johansen B, Hayes G, McGray P, Chow EP, Tizard R, Pepinsky RB (1989) Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 264:5768\u20135775","journal-title":"J Biol Chem"},{"key":"757_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.RES.86.6.707","volume":"86","author":"P Sartipy","year":"2000","unstructured":"Sartipy P, Johansen B, G\u00e2svik K, Hurt-Camejo E (2000) Molecular basis for the association of group IIA phospholipase A2 and decorin in human atherosclerotic lesions. Circ Res 86:707\u2013714","journal-title":"Circ Res"},{"key":"757_CR33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(02)03401-4","volume":"531","author":"L Fuentes","year":"2002","unstructured":"Fuentes L, Hern\u00e1ndez M, Nieto ML, Crespo MS (2002) Biological effects of group IIA secreted phospholipase A2. FEBS Lett 531:7\u201311","journal-title":"FEBS Lett"},{"key":"757_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M400253-JLR200","volume":"46","author":"SA Ghesquiere","year":"2005","unstructured":"Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP (2005) Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition. J Lipid Res 46:201\u2013210","journal-title":"J Lipid Res"},{"key":"757_CR35","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.4049\/jimmunol.176.11.7000","volume":"176","author":"S Levick","year":"2006","unstructured":"Levick S, Loch D, Rolfe B, Reid RC, Fairlie DP, Taylor SM, Brown L (2006) Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats. J Immunol 176:7000\u20137007","journal-title":"J Immunol"},{"key":"757_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1097-0029(19980901)42:5<317::AID-JEMT3>3.0.CO;2-M","volume":"42","author":"JT Daniels","year":"1998","unstructured":"Daniels JT, Occleston NL, Crowston JG, Cordeiro MF, Alexander RA, Wilkins M, Porter R, Brown R, Khaw PT (1998) Understanding and controlling the scarring response: the contribution of histology and microscopy. Microsc Res Tech 42:317\u2013333","journal-title":"Microsc Res Tech"},{"key":"757_CR37","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112:1446\u20131454","journal-title":"Arch Ophthalmol"},{"key":"757_CR38","first-page":"679","volume":"42","author":"H Mietz","year":"2001","unstructured":"Mietz H, Schl\u00f6tzer-Schrehardt U, Strassfeld C, Krieglstein GK (2001) Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci 42:679\u2013687","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"757_CR39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00166608","volume":"233","author":"R Nuzzi","year":"1995","unstructured":"Nuzzi R, Vercelli A, Finazzo C, Cracco C (1995) Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 233:154\u2013162","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"757_CR40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.ATV.18.4.519","volume":"l18","author":"M Romano","year":"1998","unstructured":"Romano M, Romano E, Bj\u00f6rkerud S, Hurt-Camejo E (1998) Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries. Arterioscler Thromb Vasc Bio l18:519\u2013525","journal-title":"Arterioscler Thromb Vasc Bio"},{"key":"757_CR41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.ATV.20.3.751","volume":"20","author":"M Menschikowski","year":"2000","unstructured":"Menschikowski M, Rosner-Schiering A, Eckey R, Mueller E, Koch R, Jaross W (2000) Expression of secretory group IIA phospholipase A2 in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissues. Arterioscler Thromb Vasc Biol 20:751\u2013762","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"757_CR42","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","volume":"111","author":"C Baudouin","year":"2004","unstructured":"Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F (2004) Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 111:2186\u20132192","journal-title":"Ophthalmology"},{"key":"757_CR43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2004.08.028","volume":"139","author":"G Manni","year":"2005","unstructured":"Manni G, Centofanti M, Oddone F, Parravano M, Bucci MG (2005) Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Am J Ophthalmol 139:72\u201377","journal-title":"Am J Ophthalmol"},{"key":"757_CR44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00947066","volume":"235","author":"H Mietz","year":"1997","unstructured":"Mietz H, Schlotzer-Schrehardt U, Lemke JH, Krieglstein GK (1997) Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone. Graefes Arch Clin Exp Ophthalmol 235:452\u2013459","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"757_CR45","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1167\/iovs.03-1067","volume":"45","author":"PJ Pisella","year":"2004","unstructured":"Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, Baudouin C (2004) Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 45:1360\u20131368","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"757_CR46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0161-6420(92)32001-9","volume":"99","author":"IR Schwab","year":"1992","unstructured":"Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM (1992) Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 99:197\u2013202","journal-title":"Ophthalmology"},{"key":"757_CR47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s004170100328","volume":"239","author":"C Costagliola","year":"2001","unstructured":"Costagliola C, Prete AD, Incorvaia C, Fusco R, Parmeggiani F, Di Giovanni A (2001) Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 239:809\u2013814","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"757_CR48","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1167\/iovs.05-0776","volume":"46","author":"JM Guenoun","year":"2005","unstructured":"Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F (2005) In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 46:4594\u20134599","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-007-0757-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0757-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T16:37:08Z","timestamp":1737823028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-007-0757-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s00417-007-0757-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}